Sang-Hoon Kim

President presso BUKWANG PHARMACEUTICAL CO., LTD.

Patrimonio netto: 3 M $ in data 31/03/2024

56 anni

Health Technology

Consumer Services

Profilo

Sang-Hoon Kim is currently working as the Co-President, Director & Chief Strategy Officer at Bukwang Pharmaceutical Co., Ltd.
He is also a Director at Contera Pharma ApS and Dyna Therapeutics Co., Ltd.
Mr. Kim completed his undergraduate degree at Boston University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
BUKWANG PHARMACEUTICAL CO., LTD. 0.80%	31/12/2022	568 504 ( 0.80% )	3 M $	31/03/2024

Posizioni attive di Sang-Hoon Kim

Società	Posizione	Inizio
BUKWANG PHARMACEUTICAL CO., LTD.	President	15/03/2013
Contera Pharma ApS Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark.	Director/Board Member	-
Dyna Therapeutics Co., Ltd.	Director/Board Member	-

Tutte le posizioni attive di Sang-Hoon Kim

Formazione di Sang-Hoon Kim

Boston University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sang-Hoon Kim

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BUKWANG PHARMACEUTICAL CO., LTD.	Health Technology

Aziende private	2
Contera Pharma ApS Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark.	Health Technology
Dyna Therapeutics Co., Ltd.